Acquired by Coherus in Sep 2023
SURF - Surface Oncology, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Cambridge,
United States
Type: Equity
SURF price evolution
SURF
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.84 | $30.58 | $52.51 | $66.69 |
| Short term investments | $41.42 | $73.07 | $73.91 | $81.25 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $60.59 | $107.21 | $129.14 | $150.12 |
| Long term investments | ||||
| Property, plant & equipment | $5.42 | $28.2 | $29.17 | $29.81 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $5.42 | $29.8 | $30.77 | $31.5 |
| Total investments | $41.42 | $73.07 | $73.91 | $81.25 |
| Total assets | $66.01 | $137.01 | $159.91 | $181.62 |
| Current liabilities | ||||
| Accounts payable | $0.61 | $1.11 | $0.26 | $0.54 |
| Deferred revenue | ||||
| Short long term debt | $9.49 | $9.03 | $5.79 | $5.76 |
| Total current liabilities | $16.83 | $14.75 | $16.26 | $17.99 |
| Long term debt | $46.43 | $25.59 | $50.81 | |
| Total noncurrent liabilities | $46.43 | $50.25 | $50.81 | |
| Total debt | $9.49 | $55.46 | $56.04 | $56.57 |
| Total liabilities | $16.83 | $61.18 | $66.51 | $68.8 |
| Shareholders' equity | ||||
| Retained earnings | -$252.26 | -$224.07 | -$204.33 | -$183 |
| Other shareholder equity | -$0.22 | -$0.57 | -$1.01 | -$1.37 |
| Total shareholder equity | $49.18 | $75.83 | $93.4 | $112.82 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $52.51 | $57.64 | $176.74 | $48.35 |
| Short term investments | $73.91 | $98.1 | $58.41 | |
| Net receivables | $0.2 | $0.77 | $2.6 | $0.3 |
| Inventory | ||||
| Total current assets | $129.14 | $157.35 | $180.51 | $107.93 |
| Long term investments | ||||
| Property, plant & equipment | $29.17 | $31.52 | $34.58 | $22.14 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $30.77 | $33.5 | $36.63 | $23.77 |
| Total investments | $73.91 | $98.1 | $58.41 | |
| Total assets | $159.91 | $190.85 | $217.14 | $131.69 |
| Current liabilities | ||||
| Accounts payable | $0.26 | $1.55 | $1.67 | $3.38 |
| Deferred revenue | $38.59 | |||
| Short long term debt | $5.79 | $5.38 | $5.53 | $2.96 |
| Total current liabilities | $16.26 | $20.02 | $17.65 | $19.27 |
| Long term debt | $25.59 | $51.92 | $43.74 | $22.08 |
| Total noncurrent liabilities | $50.25 | $51.92 | $43.74 | $55.75 |
| Total debt | $56.04 | $57.31 | $49.27 | $25.04 |
| Total liabilities | $66.51 | $71.95 | $61.39 | $75.03 |
| Shareholders' equity | ||||
| Retained earnings | -$204.33 | -$140.74 | -$62.26 | -$121.59 |
| Other shareholder equity | -$1.01 | -$0.22 | $0.1 | |
| Total shareholder equity | $93.4 | $118.9 | $155.75 | $56.67 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $13.83 | $13.78 | $15.29 | $16.89 |
| Selling, general & administrative | $8.58 | $5.89 | $5.9 | $6 |
| Total operating expenses | $25.64 | $19.66 | $21.18 | $22.9 |
| Operating income | -$25.64 | -$19.66 | -$21.18 | -$22.9 |
| Income from continuing operations | ||||
| EBIT | -$25.08 | -$18.81 | -$20.43 | -$22.41 |
| Income tax expense | ||||
| Interest expense | $3.11 | $0.93 | $0.9 | $0.83 |
| Net income | ||||
| Net income | -$28.19 | -$19.74 | -$21.33 | -$23.24 |
| Income (for common shares) | -$28.19 | -$19.74 | -$21.33 | -$23.24 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $30 | $2.69 | $126.16 | $15.36 |
| Cost of revenue | ||||
| Gross Profit | $30 | $2.69 | $126.16 | $15.36 |
| Operating activities | ||||
| Research & development | $67 | $53.57 | $41.02 | $52.12 |
| Selling, general & administrative | $24.87 | $25.13 | $23.56 | $20.61 |
| Total operating expenses | $91.87 | $78.7 | $64.58 | $72.73 |
| Operating income | -$61.87 | -$76.01 | $61.59 | -$57.37 |
| Income from continuing operations | ||||
| EBIT | -$60.44 | -$75.94 | $61.59 | -$54.79 |
| Income tax expense | ||||
| Interest expense | $3.15 | $2.55 | $2.25 | |
| Net income | ||||
| Net income | -$63.59 | -$78.48 | $59.34 | -$54.79 |
| Income (for common shares) | -$63.59 | -$78.48 | $59.34 | -$54.79 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Net income | -$28.19 | -$19.74 | -$21.33 | -$23.24 |
| Operating activities | ||||
| Depreciation | $3.29 | $0.93 | $0.91 | $0.91 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.19 | $1.65 | $1.52 | $1.77 |
| Total cash flows from operations | -$19.56 | -$23.44 | -$21.75 | -$18.83 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | $0.01 | -$0.29 | -$0.06 |
| Investments | $32.08 | $1.42 | $7.82 | $0.38 |
| Total cash flows from investing | $32.07 | $1.43 | $7.53 | $0.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.01 | $0.08 | $0.04 | $8.78 |
| Net borrowings | -$28.25 | |||
| Total cash flows from financing | -$28.25 | $0.08 | $0.04 | $8.78 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$15.73 | -$21.93 | -$14.19 | -$9.73 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$63.59 | -$78.48 | $59.34 | -$54.79 |
| Operating activities | ||||
| Depreciation | $3.69 | $3.61 | $3.62 | $3.6 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.22 | $8.55 | $7.76 | $5.99 |
| Total cash flows from operations | -$59.55 | -$62.34 | $30 | -$60.14 |
| Investing activities | ||||
| Capital expenditures | -$0.5 | -$0.12 | -$0.04 | -$1.54 |
| Investments | $23.25 | -$99.13 | $58.35 | $18.5 |
| Total cash flows from investing | $22.76 | -$99.25 | $58.31 | $16.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $31.66 | $31.81 | $30.08 | $0.28 |
| Net borrowings | $10.69 | $10 | $7.14 | |
| Total cash flows from financing | $31.66 | $42.5 | $40.08 | $7.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$5.13 | -$119.1 | $128.39 | -$35.76 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 60.73M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$80.69M |
| EBIT | -$86.73M |
| Net Income | -$92.50M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | -100.00% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 0.81 |
| Cash/Share | 0.24 |
| EPS | -$1.52 |
|---|---|
| ROA | -67.95% |
| ROE | -111.71% |
| Debt/Equity | 0.71 |
|---|---|
| Net debt/EBITDA | -0.02 |
| Current ratio | 3.60 |
| Quick ratio | 3.60 |